Prognostic factors after curative resection for gastric cancer. A population-based study

被引:107
作者
Msika, S
Benhamiche, AM
Jouve, JL
Rat, P
Faivre, J
机构
[1] INSERM, CRI 9505, Registre Bourguignon Canc Digestifs, F-21033 Dijon, France
[2] Hop Louis Mourier, Digest & Gen Surg Unit, F-92701 Colombes, France
[3] INSERM, DGS, Registre Associe, F-21033 Dijon, France
关键词
gastric cancer; resection for cure; prognostic factors; relative survival; cancer registry;
D O I
10.1016/S0959-8049(99)00308-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study was to document patterns of survival after resection for cure for gastric cancer in a well-defined Population A population-based series of 649 gastric cancers resected for cure between 1976 and 1995 in a 494000 population, was used. Resection for cure was performed in 44.4% of the diagnosed cases. This proportion increased From 36.8% (1976-1979) to 45.0% (1992-1995) (P = 0.03) whilst operative mortality decreased from 18.3 to 12.7% (P=0.003). The overall crude 5-year survival rate (excluding operative mortality) was 32.6% (95% confidence interval (CI) 28.7-36.5) and the corresponding relative survival late was 40.9%. Prognosis did not improve during the study period. Stage at diagnosis was the most important prognostic factor, the 5-year relative survival rate being 81.2% (+/- 5.9) in TNM stage IA, 70.9% ( +/- 8.0) in stage IB, 50.4% (+/- 4.6) in stage II, 24.4% (+/- 3.7) in stage IIIA, 5.6% (+/-3.2) in stage IIIB and 5.2% (+/- 2.2) in stage IV. Stage at diagnosis, age, subsite and macroscopic typo of growth were independent prognostic factors. in a multivariate relative survival model. Earlier detection or development of an effective adjuvant therapy could contribute to improvement in prognosis. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:390 / 396
页数:7
相关论文
共 35 条
[1]   IMPROVING SURVIVAL IN GASTRIC-CANCER - REVIEW OF 5-YEAR SURVIVAL RATES IN ENGLISH-LANGUAGE PUBLICATIONS FROM 1970 [J].
AKOH, JA ;
MACINTYRE, IMC .
BRITISH JOURNAL OF SURGERY, 1992, 79 (04) :293-299
[2]   IMPROVING RESULTS IN THE TREATMENT OF GASTRIC-CANCER - AN 11-YEAR AUDIT [J].
AKOH, JA ;
SEDGWICK, DM ;
MACINTYRE, IMC .
BRITISH JOURNAL OF SURGERY, 1991, 78 (03) :349-351
[3]   GASTRIC-CANCER - A 25-YEAR REVIEW [J].
ALLUM, WH ;
POWELL, DJ ;
MCCONKEY, CC ;
FIELDING, JWL .
BRITISH JOURNAL OF SURGERY, 1989, 76 (06) :535-540
[4]  
ARSENE D, 1995, GASTROEN CLIN BIOL, V19, P797
[5]   Extended lymph-node dissection for gastric cancer [J].
Bonenkamp, JJ ;
Hermans, J ;
Sasako, M ;
van de Velde, CJH .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (12) :908-914
[6]  
BORRMANN R, 1926, HDB SPEZIELLEN PATHO, P865
[7]   Patient survival after D1 and D2 resections for gastric cancer:: long-term results of the MRC randomized surgical trial [J].
Cuschieri, A ;
Weeden, S ;
Fielding, J ;
Bancewicz, J ;
Craven, J ;
Joypaul, V ;
Sydes, M ;
Fayers, P .
BRITISH JOURNAL OF CANCER, 1999, 79 (9-10) :1522-1530
[8]  
DIXON WJ, 1992, BMDP DYNAMIC 7 0 MAN
[9]  
ELIAS D, 1988, GASTROEN CLIN BIOL, V12, P729
[10]   RELATIVE SURVIVAL AND THE ESTIMATION OF NET SURVIVAL - ELEMENTS FOR FURTHER DISCUSSION [J].
ESTEVE, J ;
BENHAMOU, E ;
CROASDALE, M ;
RAYMOND, L .
STATISTICS IN MEDICINE, 1990, 9 (05) :529-538